These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34160779)

  • 1. A case of lipoprotein glomerulopathy in a Greek Caucasian male.
    Marinaki S; Kalaitzakis E; Kolovou K; Gakiopoulou H; Stylianou K; Papasotiriou M; Boletis IN
    Int Urol Nephrol; 2022 Apr; 54(4):969-970. PubMed ID: 34160779
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
    Boumendjel R; Papari M; Gonzalez M
    Arch Pathol Lab Med; 2010 Feb; 134(2):279-82. PubMed ID: 20121619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population.
    Yang AH; Ng YY; Tarng DC; Chen JY; Shiao MS; Kao JT
    Nephron; 1998; 78(3):266-70. PubMed ID: 9546684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein glomerulopathy: a case report].
    Han HL; Lin S; Song L; Sun LS; Liang H; Zhao LQ; Zhai DP
    Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):443-4. PubMed ID: 16251059
    [No Abstract]   [Full Text] [Related]  

  • 5. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein glomerulopathy: a new role for apolipoprotein E?
    Karet FE; Lifton RP
    J Am Soc Nephrol; 1997 May; 8(5):840-2. PubMed ID: 9176856
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipoprotein glomerulopathy].
    Saito T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():112-6. PubMed ID: 17899837
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 9. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
    Saito T; Matsunaga A
    J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiopathology of lipoprotein glomerulopathy].
    Saito T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1838-44. PubMed ID: 17037324
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein glomerulopathy and its pathogenesis.
    Saito T; Oikawa S; Sato H; Chiba J
    Contrib Nephrol; 1997; 120():30-8. PubMed ID: 9257045
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
    Oikawa S; Suzuki N; Sakuma E; Saito T; Namai K; Kotake H; Fujii Y; Toyota T
    Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein glomerulopathy].
    Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():353-60. PubMed ID: 11347095
    [No Abstract]   [Full Text] [Related]  

  • 14. [New evolution in lipoprotein glomerulopathy].
    Saito T; Matsunaga A; Nakashima H
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1314-9. PubMed ID: 24288968
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathologic features of lipoprotein glomerulopathy: observation of 6 cases].
    Zou GM; Zhuo L; Tan M; Li WG
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2910-2913. PubMed ID: 30293348
    [No Abstract]   [Full Text] [Related]  

  • 16. Topics in lipoprotein glomerulopathy: an overview.
    Saito T; Matsunaga A; Ito K; Nakashima H
    Clin Exp Nephrol; 2014 Apr; 18(2):214-7. PubMed ID: 24149835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.
    Miyata T; Sugiyama S; Nangaku M; Suzuki D; Uragami K; Inagi R; Sakai H; Kurokawa K
    J Am Soc Nephrol; 1999 Jul; 10(7):1590-5. PubMed ID: 10405216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.
    Stratikos E; Chroni A
    Clin Exp Nephrol; 2014 Apr; 18(2):225-9. PubMed ID: 24149834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of a paediatric case of lipoprotein glomerulopathy.
    Koitabashi Y; Ikoma M; Miyahira T; Fujita R; Mio H; Ishida M; Shimizu K; Sakaguchi H
    Pediatr Nephrol; 1990 Mar; 4(2):122-8. PubMed ID: 2397177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pathological analyses of lipoprotein glomerulopathy].
    Hu ZX; Zhang XH; Sha ZH; Yang LC; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):442-4. PubMed ID: 15181857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.